ID
45858
Beskrivning
Principal Investigator: Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001018 We performed comprehensive molecular profiling of renal tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of response and resistance to existing and emerging therapies in this disease, as well as mechanisms of tumor evolution in the context of treatment.
Länk
Nyckelord
Versioner (1)
- 2023-10-08 2023-10-08 - Simon Heim
Rättsinnehavare
Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
Uppladdad den
8 oktober 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001018 Molecular Characterization of Clinical Renal Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
C0680251 (UMLS CUI [1,2])
C0740457 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0475358 (UMLS CUI [1,4])
C3845275 (UMLS CUI [1,5])